1. Home
  2. OFIX vs OBIO Comparison

OFIX vs OBIO Comparison

Compare OFIX & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

N/A

Current Price

$9.07

Market Cap

409.0M

Sector

Health Care

ML Signal

N/A

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$5.89

Market Cap

362.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFIX
OBIO
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.0M
362.4M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
OFIX
OBIO
Price
$9.07
$5.89
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
★ $13.00
$12.43
AVG Volume (30 Days)
★ 336.2K
318.3K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
★ 33.13
EPS
N/A
★ N/A
Revenue
★ $822,312,000.00
$33,482,000.00
Revenue This Year
$3.51
N/A
Revenue Next Year
$2.64
$33.45
P/E Ratio
★ N/A
N/A
Revenue Growth
2.85
★ 1169.22
52 Week Low
$8.50
$3.46
52 Week High
$16.99
$6.50

Technical Indicators

Market Signals
Indicator
OFIX
OBIO
Relative Strength Index (RSI) 42.76 53.59
Support Level $8.83 $5.71
Resistance Level $9.92 $6.17
Average True Range (ATR) 0.42 0.30
MACD 0.01 0.02
Stochastic Oscillator 12.54 67.50

Price Performance

Historical Comparison
OFIX
OBIO

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: